Processa Pharmaceuticals, Inc. · NASDAQ:PCSA
Processa Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 11 institutions reported holding Processa Pharmaceuticals, Inc., 9.1% of its shares. Largest: Connective Capital Management, LLC, Stonepine Capital Management, LLC and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Processa Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Connective Capital Management, LLC | 85,274 | 3.1% | +14,538 | Aug 13, 2026 |
| Stonepine Capital Management, LLC | 55,000 | 2.0% | no change | Aug 17, 2026 |
| Vanguard | 23,586 | 0.84% | no change | Aug 13, 2026 |
| Geode Capital | 22,090 | 0.79% | −2,818 | Aug 12, 2026 |
| Citadel | 21,306 | 0.76% | new | Aug 14, 2026 |
| XTX Topco Ltd | 13,292 | 0.48% | new | Aug 14, 2026 |
| Jane Street | 13,264 | 0.47% | new | Aug 14, 2026 |
| StoneX Group Inc. | 11,437 | 0.41% | new | Aug 12, 2026 |
| UBS | 7,794 | 0.28% | +5,263 | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 2,499 | 0.09% | +1,581 | Aug 11, 2026 |